NO20052598D0 - Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem. - Google Patents
Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.Info
- Publication number
- NO20052598D0 NO20052598D0 NO20052598A NO20052598A NO20052598D0 NO 20052598 D0 NO20052598 D0 NO 20052598D0 NO 20052598 A NO20052598 A NO 20052598A NO 20052598 A NO20052598 A NO 20052598A NO 20052598 D0 NO20052598 D0 NO 20052598D0
- Authority
- NO
- Norway
- Prior art keywords
- dihydro
- processes
- preparation
- new
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213803A FR2846654A1 (fr) | 2002-11-05 | 2002-11-05 | Nouveaux derives de la 2,3-dihydro-4(1h)-pyridinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2003/003276 WO2004043952A1 (fr) | 2002-11-05 | 2003-11-04 | Nouveaux derives de 2,3-dihydro-4(1h)-pyridinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052598D0 true NO20052598D0 (no) | 2005-05-30 |
| NO20052598L NO20052598L (no) | 2005-05-30 |
Family
ID=32104441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052598A NO20052598L (no) | 2002-11-05 | 2005-05-30 | Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060019995A1 (no) |
| EP (1) | EP1560825A1 (no) |
| JP (1) | JP2006508110A (no) |
| KR (1) | KR20050084942A (no) |
| CN (1) | CN1705660A (no) |
| AR (1) | AR041758A1 (no) |
| AU (1) | AU2003292322A1 (no) |
| BR (1) | BR0315996A (no) |
| CA (1) | CA2503993A1 (no) |
| EA (1) | EA200500716A1 (no) |
| FR (1) | FR2846654A1 (no) |
| MA (1) | MA27407A1 (no) |
| MX (1) | MXPA05004793A (no) |
| NO (1) | NO20052598L (no) |
| PL (1) | PL375959A1 (no) |
| WO (1) | WO2004043952A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101680818B1 (ko) | 2008-12-22 | 2016-11-29 | 케모센트릭스, 인크. | Ｃ5ａｒ 길항제 |
| WO2011163640A1 (en) | 2010-06-24 | 2011-12-29 | Chemocentryx, Inc. | C5ar antagonists |
| FR3004107A1 (fr) * | 2013-04-08 | 2014-10-10 | Univ Rennes | Composes photoprotecteurs, compositions les comprenant, et leurs utilisations |
| CN104109113B (zh) * | 2013-04-17 | 2016-01-27 | 中国科学院化学研究所 | 多取代二氢吡啶-4-酮类化合物及其制备方法与应用 |
| US9745268B2 (en) | 2014-09-29 | 2017-08-29 | Chemocentryx, Inc. | Processes and intermediates in the preparation of C5aR antagonists |
| EP3402486A4 (en) | 2016-01-14 | 2019-08-28 | ChemoCentryx, Inc. | PROCESS FOR TREATING C3 GLOMERULOPATHY |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2013761A1 (en) * | 1970-03-21 | 1971-10-07 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | 4-azacycloalk-2-enone prepn |
| FR2793246B1 (fr) * | 1999-05-03 | 2001-06-29 | Adir | Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2002
- 2002-11-05 FR FR0213803A patent/FR2846654A1/fr active Pending
-
2003
- 2003-11-04 EA EA200500716A patent/EA200500716A1/ru unknown
- 2003-11-04 PL PL03375959A patent/PL375959A1/xx not_active Application Discontinuation
- 2003-11-04 CN CNA2003801018233A patent/CN1705660A/zh active Pending
- 2003-11-04 WO PCT/FR2003/003276 patent/WO2004043952A1/fr not_active Application Discontinuation
- 2003-11-04 US US10/533,784 patent/US20060019995A1/en not_active Abandoned
- 2003-11-04 EP EP03767888A patent/EP1560825A1/fr not_active Withdrawn
- 2003-11-04 AU AU2003292322A patent/AU2003292322A1/en not_active Abandoned
- 2003-11-04 CA CA002503993A patent/CA2503993A1/fr not_active Abandoned
- 2003-11-04 KR KR1020057007992A patent/KR20050084942A/ko not_active Application Discontinuation
- 2003-11-04 BR BR0315996-5A patent/BR0315996A/pt not_active IP Right Cessation
- 2003-11-04 JP JP2004550728A patent/JP2006508110A/ja active Pending
- 2003-11-04 AR ARP030104025A patent/AR041758A1/es unknown
- 2003-11-04 MX MXPA05004793A patent/MXPA05004793A/es not_active Application Discontinuation
-
2005
- 2005-04-14 MA MA28221A patent/MA27407A1/fr unknown
- 2005-05-30 NO NO20052598A patent/NO20052598L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0315996A (pt) | 2005-09-27 |
| AU2003292322A1 (en) | 2004-06-03 |
| CN1705660A (zh) | 2005-12-07 |
| MXPA05004793A (es) | 2005-07-22 |
| MA27407A1 (fr) | 2005-06-01 |
| CA2503993A1 (fr) | 2004-05-27 |
| NO20052598L (no) | 2005-05-30 |
| EP1560825A1 (fr) | 2005-08-10 |
| WO2004043952A1 (fr) | 2004-05-27 |
| AR041758A1 (es) | 2005-05-26 |
| FR2846654A1 (fr) | 2004-05-07 |
| KR20050084942A (ko) | 2005-08-29 |
| JP2006508110A (ja) | 2006-03-09 |
| EA200500716A1 (ru) | 2005-10-27 |
| US20060019995A1 (en) | 2006-01-26 |
| PL375959A1 (en) | 2005-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052683D0 (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20032926D0 (no) | Heterocykliske forbindelser som har antibakteriell aktivitet, fremgangsmåtefor deres fremstilling og farmasöytiske sammensetningerinneholdende dem | |
| NO20052493D0 (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| NO20023643D0 (no) | Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem | |
| NO20052598D0 (no) | Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem. | |
| DK1183256T3 (da) | Puridinderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem | |
| NO20010522D0 (no) | Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20055167D0 (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20055835L (no) | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20026154L (no) | Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20043188L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20031219D0 (no) | Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20010305D0 (no) | Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20031643L (no) | Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK1395582T3 (da) | Hidtil ukendte piperidincarboxamidderivater, en fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem | |
| NO20034614L (no) | Nye [3,4-a:3,4-c]karbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20042978L (no) | Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20041313L (no) | Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20035215L (no) | Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20021330D0 (no) | Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20050391D0 (no) | Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20042422L (no) | Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20052330D0 (no) | Nye substituerte [1,4]benzodioksino[2,3]isoindolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20021198L (no) | Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20043880L (no) | Nye benzoindolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |